Eli Lilly and Company
Hedge Funds Holdings
Last updated:
Eli Lilly and Company‘s stocks are currently a part of 2248 hedge funds’ portfolios, which represents 85.49% of the total amount of its stocks outstanding. This makes up a total of 779.43M shares of Eli Lilly and Company. Compared to the previous quarter, the number fell by -1.09% or -8.60M shares fewer. As for the holding position changes, 38.48% (865) of current hedge fund investors increased the number of shares held, 36.7% (825) of current holders sold a part of the shares held, and 4.72% (106) closed the holdings completely. 152 hedge funds are new holders of Eli Lilly and Company stock in Q1 2022, it is 6.76% of total holders.
Hedge funds holding Eli Lilly and Company (Q2 2017 – Q1 2022)
| Q2 2017 | 1,236 |
|---|---|
| Q3 2017 | 1,214 |
| Q4 2017 | 1,360 |
| Q1 2018 | 1,318 |
| Q2 2018 | 1,352 |
| Q3 2018 | 1,415 |
| Q4 2018 | 1,544 |
| Q1 2019 | 1,584 |
| Q2 2019 | 1,495 |
| Q3 2019 | 1,503 |
| Q4 2019 | 1,646 |
| Q1 2020 | 1,657 |
| Q2 2020 | 1,735 |
| Q3 2020 | 1,744 |
| Q4 2020 | 1,849 |
| Q1 2021 | 1,910 |
| Q2 2021 | 1,978 |
| Q3 2021 | 2,003 |
| Q4 2021 | 2,237 |
| Q1 2022 | 2,248 |
Hedge funds changes in Eli Lilly and Company positions (Q2 2017 – Q1 2022)
| Q2 2017 | 82 | 411 | 496 | 67 | 180 |
|---|---|---|---|---|---|
| Q3 2017 | 64 | 403 | 484 | 74 | 189 |
| Q4 2017 | 207 | 447 | 466 | 49 | 191 |
| Q1 2018 | 94 | 428 | 558 | 120 | 118 |
| Q2 2018 | 120 | 421 | 540 | 78 | 193 |
| Q3 2018 | 144 | 428 | 529 | 71 | 243 |
| Q4 2018 | 224 | 454 | 588 | 87 | 191 |
| Q1 2019 | 149 | 438 | 753 | 101 | 143 |
| Q2 2019 | 88 | 474 | 656 | 152 | 125 |
| Q3 2019 | 86 | 505 | 623 | 71 | 218 |
| Q4 2019 | 232 | 518 | 577 | 66 | 253 |
| Q1 2020 | 122 | 551 | 659 | 90 | 235 |
| Q2 2020 | 171 | 577 | 676 | 80 | 231 |
| Q3 2020 | 135 | 620 | 658 | 112 | 219 |
| Q4 2020 | 229 | 649 | 668 | 107 | 196 |
| Q1 2021 | 177 | 662 | 760 | 98 | 213 |
| Q2 2021 | 179 | 702 | 741 | 94 | 262 |
| Q3 2021 | 124 | 716 | 778 | 81 | 304 |
| Q4 2021 | 345 | 844 | 666 | 87 | 295 |
| Q1 2022 | 152 | 865 | 825 | 106 | 300 |
Hedge funds changes in Eli Lilly and Company stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 110,382,814,661 | 109,534,165,565 |
|---|---|---|
| Q3 2017 | 127,380,246,480 | 12,501,689,262 |
| Q4 2017 | 37,527,947,626 | 59,540,249,458 |
| Q1 2018 | 4,323,786,699 | 104,389,271,310 |
| Q2 2018 | 7,367,531,500 | 7,391,673,357 |
| Q3 2018 | 47,702,455,787 | 879,803,010 |
| Q4 2018 | 6,739,243,392 | 57,790,149,244 |
| Q1 2019 | 1,616,344,192 | 16,230,549,824 |
| Q2 2019 | 435,687,853 | 16,536,285,304 |
| Q3 2019 | 456,537,320 | 26,472,353,060 |
| Q4 2019 | 222,604,786,332 | 79,750,716,509 |
| Q1 2020 | 476,639,979,744 | 4,254,664,415,008 |
| Q2 2020 | 6,677,018,150 | 823,799,387,554 |
| Q3 2020 | 431,191,406 | 11,154,694,858,594 |
| Q4 2020 | 1,988,868,262,644 | 12,690,794,440,612 |
| Q1 2021 | 4,492,966,817,324 | 16,858,109,180,128 |
| Q2 2021 | 1,407,045,496 | 10,901,704,853,912 |
| Q3 2021 | 595,343,930,830 | 15,518,843,278,330 |
| Q4 2021 | 1,931,531,872 | 15,456,351,218,848 |
| Q1 2022 | 1,356,624,908 | 1,526,995,546 |